Health in 2 Point 00

Health in 2 Point 00, Episode 151| MDLive (not?) IPOing, DTx Platform for Schizophrenia, & more

We are forgetting about health tech, and celebrating Chicago-oo! Just kidding, today on Health in 2 Point 00, Jess asks me about Truepill getting a 75M Series C after just closing their B, Sana Benefits getting $20.8M, and Decent getting $10M, both of which are in the space of health benefits & insurance for small business have raised funding, MDLive closing a $50M round for their Virtual Primary Care (but weren’t they going public?), Owl Insights getting $15M from Ascension and Blue Ventures, and Boehringer Ingelheim & Click Therapeutics working on a $500M deal together on a DTx platform for Schizophrenia patients. –Matthew Holt

Subscribe to Health in 2 Point 00’s Channel

Follow @boltyboy & @jessdamassa on Twitter

Subscribe to our channel and tweet us your questions using the hashtag #healthin2point00!

Livongo’s Post Ad Banner 728*90
Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *